Roubaix Capital’s BioLife Solutions BLFS Stock Holding History

Roubaix Capital’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.74M	Buy	+309,618	New	+$7.24M	3.14%	3
2024 Q2	–	Sell	-123,199	Closed	-$2.29M	–	51
2024 Q1	$2.29M	Sell	123,199 -157,138	-56%	-$2.75M	1.45%	31
2023 Q4	$4.56M	Buy	280,337 +133,439	+91%	+$1.7M	3.19%	9
2023 Q3	$2.03M	Buy	+146,898	New	+$2.31M	1.5%	36
2020 Q2	–	Sell	-221,008	Closed	-$2.1M	–	52
2020 Q1	$2.1M	Buy	221,008 +82,700	+60%	+$1.14M	3.19%	10
2019 Q4	$2.24M	Buy	138,308 +58,584	+73%	+$952K	2.15%	25
2019 Q3	$1.32M	Sell	79,724 -40,589	-34%	-$762K	1.21%	31
2019 Q2	$2.04M	Buy	120,313 +75,068	+166%	+$1.31M	1.7%	27
2019 Q1	$809K	Buy	+45,245	New	+$720K	0.8%	38

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Roubaix Capital's BLFS Position: Q2 2026 in Review

Roubaix Capital opened a new position in BioLife Solutions (BLFS) in Q2 2026: 309,618 shares worth $8.74M. The stake represents 3.14% of the portfolio and ranks #3 among its holdings. This is a return to the name: Roubaix Capital previously reported a position in BLFS as recently as Q1 2024.

Roubaix Capital first reported a position in BLFS in Q1 2019 and has held it in 9 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Roubaix Capital held 309,618 shares of BioLife Solutions worth $8.74M as of Q2 2026.
BioLife Solutions was a new Roubaix Capital position in Q2 2026.
BioLife Solutions made up 3.14% of Roubaix Capital's portfolio in Q2 2026, its #3 holding.
Roubaix Capital first reported a position in BioLife Solutions in Q1 2019 and has held it in 9 quarters since.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Roubaix Capital's 13F filing for Q2 2026, filed 10 Aug 2026.